Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0163 | 0.5 |
Onchocerca volvulus | 0.0137 | 0.5538 | 0.5 | |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0175 | 0.7516 | 1 |
Brugia malayi | bZIP transcription factor family protein | 0.0175 | 0.7516 | 0.4433 |
Leishmania major | hypothetical protein, conserved | 0.0035 | 0.0163 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0163 | 0.5 |
Trypanosoma brucei | membrane transporter protein, putative | 0.0035 | 0.0163 | 0.5 |
Trypanosoma brucei | membrane transporter protein, putative | 0.0035 | 0.0163 | 0.5 |
Schistosoma mansoni | jun-related protein | 0.0142 | 0.5791 | 1 |
Echinococcus granulosus | jun protein | 0.0175 | 0.7516 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0163 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0222 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0035 | 0.0163 | 0.5 |
Trypanosoma brucei | membrane transporter protein, putative | 0.0035 | 0.0163 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0142 | 0.5791 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0163 | 0.5 |
Echinococcus multilocularis | multidrug and toxin extrusion protein 2 | 0.0035 | 0.0163 | 0.0217 |
Trypanosoma brucei | MATE efflux family protein, putative | 0.0035 | 0.0163 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0175 | 0.7516 | 1 |
Echinococcus multilocularis | jun protein | 0.0175 | 0.7516 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0163 | 0.5 |
Trypanosoma cruzi | membrane transporter protein, putative | 0.0035 | 0.0163 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 9.4 uM | Antiproliferative activity against PDGF-induced rat aortic VSMC by colorimetric assay | ChEMBL. | 18400498 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.